We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+14.8%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.85B
AUM Growth
+$181M
Cap. Flow
+$27.3M
Cap. Flow %
1.48%
Top 10 Hldgs %
26.18%
Holding
272
New
16
Increased
74
Reduced
154
Closed
22

Top Buys

Rank Stock Value
1
WEX icon
WEX
WEX
+$25M
2
DOX icon
Amdocs
DOX
+$10.9M
3
ETSY icon
Etsy
ETSY
+$9.39M
4
GNTX icon
Gentex
GNTX
+$8.86M
5
MGPI icon
MGP Ingredients
MGPI
+$6.5M

Top Sells

Rank Stock Value
1
AX icon
Axos Financial
AX
+$16.8M
2
PCRX icon
Pacira BioSciences
PCRX
+$12.5M
3
ADMA icon
ADMA Biologics
ADMA
+$11.5M
4
ACIW icon
ACI Worldwide
ACIW
+$9.89M
5
RXO icon
RXO
RXO
+$8.37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.6%
2 Technology 28.67%
3 Industrials 15.74%
4 Consumer Staples 6.67%
5 Communication Services 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
101
Pacira BioSciences
PCRX
$997M
$4.04M 0.22%
268,337
-730,288
-73% -$12.5M
HLIT icon
102
Harmonic Inc
HLIT
$1.28B
$4.03M 0.22%
276,406
-1,778
-0.6% -$23.7K
HWKN icon
103
Hawkins
HWKN
$2.71B
$4.02M 0.22%
+31,502
New +$3.57M
CNTY icon
104
Century Casinos
CNTY
$34M
$3.92M 0.21%
1,530,061
+325,890
+27% +$801K
TNDM icon
105
Tandem Diabetes Care
TNDM
$1.56B
$3.91M 0.21%
92,258
-1,035
-1% -$43.9K
DCBO
106
Docebo
DCBO
$566M
$3.91M 0.21%
+88,384
New +$3.62M
MIR icon
107
Mirion Technologies
MIR
$3.91B
$3.9M 0.21%
352,737
+131,453
+59% +$1.38M
ICFI icon
108
ICF International
ICFI
$1.72B
$3.82M 0.21%
22,893
-250
-1% -$38.4K
OR icon
109
OR Royalties Inc
OR
$6.2B
$3.81M 0.21%
206,057
-27,319
-12% -$472K
MLTX icon
110
MoonLake Immunotherapeutics
MLTX
$1.55B
$3.81M 0.21%
+75,469
New +$3.54M
RVNC
111
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.79M 0.21%
730,190
+18,118
+3% +$90K
GPGI
112
GPGI Inc
GPGI
$4.35B
$3.77M 0.2%
+323,406
New +$2.74M
HAE icon
113
Haemonetics
HAE
$4B
$3.76M 0.2%
46,727
-604
-1% -$48.8K
CBZ icon
114
CBIZ
CBZ
$2.96B
$3.71M 0.2%
55,076
-96
-0.2% -$6.98K
KTOS icon
115
Kratos Defense & Security Solutions
KTOS
$11.4B
$3.67M 0.2%
157,606
-1,751
-1% -$37.9K
BV icon
116
BrightView Holdings
BV
$1.07B
$3.65M 0.2%
231,835
+45,793
+25% +$664K
ANIP icon
117
ANI Pharmaceuticals
ANIP
$1.78B
$3.6M 0.19%
60,375
-297
-0.5% -$18.1K
IRMD icon
118
iRadimed
IRMD
$1.18B
$3.6M 0.19%
71,599
-439
-0.6% -$20.3K
LKQ icon
119
LKQ Corp
LKQ
$6.29B
$3.48M 0.19%
87,215
-16,065
-16% -$662K
AMSC icon
120
American Superconductor
AMSC
$1.59B
$3.47M 0.19%
147,192
-1,096
-0.7% -$25.3K
ACLS icon
121
Axcelis
ACLS
$4.33B
$3.47M 0.19%
33,111
-285
-0.9% -$33.3K
APG icon
122
APi Group
APG
$18B
$3.46M 0.19%
157,289
-47,796
-23% -$1.12M
URGN icon
123
UroGen Pharma
URGN
$2.29B
$3.45M 0.19%
271,897
+199,110
+274% +$2.96M
SNBR
124
DELISTED
Sleep Number
SNBR
$3.43M 0.19%
187,469
+7,080
+4% +$92.7K
ALG icon
125
Alamo Group
ALG
$2.05B
$3.41M 0.18%
18,913
-139
-0.7% -$24.8K
3 4
5
6 7

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Rice Hall James & Associates held 272 positions worth $1.85B, up 11% from $1.67B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2024 filing shows 16 new, 74 increased, 154 reduced and 22 closed positions. Its largest new stake was Gentex: 285,297 shares worth $8.47M. The largest sale was Axos Financial, an estimated $16.8M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2024 buy was Gentex: 285,297 shares worth $8.47M.
  • Rice Hall James & Associates added most to WEX in Q3 2024, an estimated $25M increase.
  • Rice Hall James & Associates's biggest Q3 2024 reduction was Axos Financial, cutting an estimated $16.8M.
  • Rice Hall James & Associates fully exited RXO in Q3 2024, selling an estimated $8.37M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.85B portfolio in Q3 2024.
  • Rice Hall James & Associates opened 16 new positions and closed 22 in Q3 2024.
  • Rice Hall James & Associates's portfolio value rose 11% quarter-over-quarter to $1.85B.

Based on Rice Hall James & Associates's 13F filing for Q3 2024, filed 28 Oct 2024.